Clinical Trial Update: LEAF - Low Energy In Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for LEAF (Low Energy In Atrial Fibrillation) device by Medtronic. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Tachyarrhythmia

Drugs mentioned

• LEAF device

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Atrial Fibrillation, Atrial Tachyarrhythmia | Phase 4 | Status: COMPLETED